Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
208.16
+6.26 (3.10%)
At close: Mar 9, 2026, 4:00 PM EDT
204.12
-4.04 (-1.94%)
After-hours: Mar 9, 2026, 4:23 PM EDT

Ligand Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
174.9372.3122.9545.0119.52
Upgrade
Short-Term Investments
558.59183.86147.36166.86321.59
Upgrade
Cash & Short-Term Investments
733.52256.17170.31211.87341.11
Upgrade
Cash Growth
186.35%50.41%-19.62%-37.89%-17.04%
Upgrade
Accounts Receivable
82.3948.432.9230.4285.45
Upgrade
Other Receivables
1.454.076.44.616.19
Upgrade
Receivables
83.8452.4739.3135.0491.65
Upgrade
Inventory
9.1314.1123.9713.2927.33
Upgrade
Prepaid Expenses
--1.181.13-
Upgrade
Other Current Assets
5.798.812.662.274.67
Upgrade
Total Current Assets
832.27331.56237.43263.6464.75
Upgrade
Property, Plant & Equipment
7.229.6725.0627.4932.6
Upgrade
Long-Term Investments
167.9510.9149.323-
Upgrade
Goodwill
101.54105.25103.37105.67105.67
Upgrade
Other Intangible Assets
225.44266.65299.61352.64386.8
Upgrade
Long-Term Accounts Receivable
196.88185.0262.29--
Upgrade
Long-Term Deferred Tax Assets
8.350.070.218.5335.73
Upgrade
Other Long-Term Assets
20.9932.649.921.74272.03
Upgrade
Total Assets
1,561941.77787.22762.671,298
Upgrade
Accounts Payable
3.245.232.435.318.4
Upgrade
Accrued Expenses
29.0825.5310.0913.312.4
Upgrade
Current Portion of Long-Term Debt
---76.7-
Upgrade
Current Portion of Leases
1.121.290.410.721.41
Upgrade
Current Income Taxes Payable
1.241.2---
Upgrade
Current Unearned Revenue
--1.220.360.65
Upgrade
Other Current Liabilities
2.783.862.632.4318.8
Upgrade
Total Current Liabilities
37.4537.1116.7898.8141.67
Upgrade
Long-Term Debt
446.19---320.72
Upgrade
Long-Term Leases
4.235.865.7710.342.31
Upgrade
Long-Term Unearned Revenue
-18.1815.140.04-
Upgrade
Long-Term Deferred Tax Liabilities
36.0232.5231.6230.6230.86
Upgrade
Other Long-Term Liabilities
19.5417.6516.9825.3780.88
Upgrade
Total Liabilities
543.43111.3486.3165.18476.43
Upgrade
Common Stock
0.020.020.020.020.02
Upgrade
Additional Paid-In Capital
400.65337.38198.7147.59372.97
Upgrade
Retained Earnings
608.09498.98503.02450.86449.09
Upgrade
Comprehensive Income & Other
8.46-5.94-0.82-0.98-0.92
Upgrade
Shareholders' Equity
1,017830.44700.91597.49821.16
Upgrade
Total Liabilities & Equity
1,561941.77787.22762.671,298
Upgrade
Total Debt
451.547.156.1887.75324.44
Upgrade
Net Cash (Debt)
281.98249.01164.13124.1216.66
Upgrade
Net Cash Growth
13.24%51.72%32.23%644.83%-
Upgrade
Net Cash Per Share
13.8913.619.247.360.97
Upgrade
Filing Date Shares Outstanding
19.9419.2617.7117.0816.85
Upgrade
Total Common Shares Outstanding
19.7719.1117.5616.9516.77
Upgrade
Working Capital
794.82294.45220.65164.79423.09
Upgrade
Book Value Per Share
51.4443.4639.9235.2548.97
Upgrade
Tangible Book Value
690.23458.54297.94139.18328.69
Upgrade
Tangible Book Value Per Share
34.9124.0016.978.2119.60
Upgrade
Machinery
--7.7815.1614.34
Upgrade
Construction In Progress
--4.12--
Upgrade
Leasehold Improvements
--10.367.455.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.